Enfusion, Inc. (NYSE:ENFN) Shares Acquired by Rhumbline Advisers

Rhumbline Advisers boosted its position in shares of Enfusion, Inc. (NYSE:ENFN) by 6.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 66,335 shares of the company’s stock after purchasing an additional 3,871 shares during the period. Rhumbline Advisers owned approximately 0.05% of Enfusion worth $740,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. GAMMA Investing LLC grew its holdings in Enfusion by 1,098.5% during the 1st quarter. GAMMA Investing LLC now owns 12,165 shares of the company’s stock valued at $136,000 after purchasing an additional 11,150 shares in the last quarter. Wellington Management Group LLP grew its holdings in Enfusion by 6.1% during the 4th quarter. Wellington Management Group LLP now owns 1,035,996 shares of the company’s stock valued at $10,671,000 after purchasing an additional 59,700 shares in the last quarter. Mackenzie Financial Corp grew its holdings in Enfusion by 4.8% during the 4th quarter. Mackenzie Financial Corp now owns 31,271 shares of the company’s stock valued at $322,000 after purchasing an additional 1,434 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Enfusion by 43.2% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 33,721 shares of the company’s stock valued at $347,000 after purchasing an additional 10,173 shares in the last quarter. Finally, Squarepoint Ops LLC grew its holdings in Enfusion by 136.2% during the 4th quarter. Squarepoint Ops LLC now owns 35,633 shares of the company’s stock valued at $367,000 after purchasing an additional 20,550 shares in the last quarter. 81.05% of the stock is owned by institutional investors and hedge funds.

Enfusion Price Performance

Shares of ENFN stock opened at $10.85 on Friday. The firm has a fifty day moving average of $10.85 and a two-hundred day moving average of $10.88. The firm has a market cap of $1.40 billion, a P/E ratio of 271.29, a P/E/G ratio of 1.85 and a beta of 0.92. Enfusion, Inc. has a 1-year low of $7.83 and a 1-year high of $11.80.

Enfusion Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.